Menu
Annual · values202620252024202320222021202020192018201720162015
Gross Margin75.53%74.53%71.35%71.72%72.79%72.09%72.52%71.55%69.16%68.08%65.25%63.07%
Operating Margin28.68%25.17%18.16%21.30%27.31%25.79%25.92%25.85%22.00%19.85%19.20%22.34%
EBITDA Margin18.42%21.58%27.69%26.40%27.72%27.48%24.08%22.39%21.27%23.59%
Net Margin28.44%26.00%22.24%22.63%23.09%25.94%27.27%26.66%20.71%12.65%13.31%12.89%
Current Ratio4.894.514.243.943.703.232.783.573.202.882.693.70
Quick Ratio4.894.514.243.943.703.232.783.573.202.882.693.70
Debt / Equity
ROE12.60%12.24%11.32%13.12%14.68%16.77%18.08%18.57%16.29%10.54%10.78%9.93%
ROA10.12%9.73%8.89%10.15%11.20%12.48%13.25%13.90%11.86%7.50%7.72%7.41%
Asset Turnover0.360.370.400.450.480.480.490.520.570.590.580.57
Book Value / Share43.2035.3028.4122.8817.9414.1010.527.935.674.423.492.82

Veeva Systems Inc. is a cloud software company focused on the life sciences industry. It provides industry-specific applications that help pharmaceutical, biotechnology, and other healthcare organizations manage customer relationships, clinical operations, quality processes, regulatory content, and commercial activities within a compliant digital environment. The company’s platform is designed to support critical workflows across development, manufacturing, and go-to-market functions, with products that emphasize data integrity, collaboration, and regulatory alignment. Veeva Systems serves a broad range of life sciences customers, from emerging biotech firms to global pharmaceutical companies, and plays a significant role in the modernization of software systems used across healthcare and regulated industries.